TREATMENT OF HYPERBILYRUBINEMIA IN NEWBORN USING LOW STANSOPORFINE DOSAGE

摘要

Methods of treating infant hyperbilirubinemia using stannsoporfin are disclosed. The methods of the invention permit treatment of various patient populations at lower doses of stannsoporfin than previously believed effective, providing advantages in therapeutic administration.